Volume 10, Number 7—July 2004
Research
Collecting Data To Assess SARS Interventions
Table A1
Column | Priority group | Variable | Type | Suggested coding | Comments/details |
---|---|---|---|---|---|
Participant information | |||||
A | 1 | Patient ID | Numeric or character | 1, 2, 3, …n | |
B | 1 | Sex | Categories | 1 = male 2 = female | |
C | 1 | Age | Continuous | e.g. 25, 26 | |
D |
3 |
Coexisting condition |
Categories |
0 = none known
1 = CVD
2 = diabetes
3 = COPD
4 = HIV/AIDS
5 = other
6 = unknown |
Important to differentiate none known from unknown |
Exposure dataa | |||||
Exposure 1 | |||||
E | 1 | Date | Date | DD/MM/YY | |
F | 1 | Source ID | Numeric or character | ID of source patient or unknown | Identify, using patient ID, the presumed source of infection |
G | 2 | Duration | Categories | 1 = <30 min 2 = 30–59 min 3 = >60 min | Other categories of duration of exposure can be used. Must define "exposure" |
H |
2 |
Locale |
Categories |
1 = home
2 = hospital
3 = other |
Other exposure locales can be added as needed |
Exposure 2 | |||||
I–L and M–P | b | c | c | c | c |
Symptoms, respiratory | |||||
Q | 1 | Symptom onset date | Date | DD/MM/YY | Need to define the term "symptom" |
R | 3 | Symptom category | Categories | d | Record all that are applicable and adjust as needed |
Symptoms, non respiratory | |||||
S | 1 | Symptom onset date | Date | DD/MM/YY | Need to define the term "symptom" |
T | 3 | Symptom category | Categories | d | Record all that are applicable and adjust as needed |
aCan expand to as many exposures as needed.
bSame as E–H.
cRepeat for each exposure.
d1 = fever; 2 = cough; 3 = myalgia; 4 = dyspnea; 5 = headache; 6 = malaise; 7 = chills; 8 = diarrhea; 9 = nausea/vomiting; 10 = sore throat; 11 = arthralgia; 12 = chest pain; 13 = productive cough; 14 = vomiting; 15 = rhinorrhea/runny nose; 16 = nonheadache neurologic symptoms (e.g., dizziness); 17 = abdominal pain.
Page created: April 23, 2012
Page updated: April 23, 2012
Page reviewed: April 23, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.